Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Capsule: SOP for Documentation of Process Deviations in Capsule Production – V 2.0

Posted on By

Capsule: SOP for Documentation of Process Deviations in Capsule Production – V 2.0

Standard Operating Procedure for Documentation of Process Deviations in Capsule Production

Department Production
SOP No. SOP/PD/221/2025
Supersedes SOP/PD/221/2022
Page No. Page 1 of 5
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

The purpose of this SOP is to outline the process for documenting and managing process deviations in capsule production. Ensuring that all deviations are identified, documented, and reviewed helps maintain product quality, safety, and compliance with GMP and regulatory requirements.

2. Scope

This SOP applies to the documentation of any process deviations that occur during the production of capsules, including manufacturing, filling, sealing, and packaging stages. It applies to all personnel involved in capsule production and quality control.

3. Responsibilities

  • Production Team: Responsible for identifying and reporting process deviations during production activities.
  • Quality Control (QC) Team: Responsible for reviewing the deviation reports and verifying the impact of the deviation on product quality.
  • Quality Assurance (QA) Team: Responsible for evaluating deviations, implementing corrective actions, and ensuring proper documentation of the deviation process.
  • Deviation Owner: Responsible for investigating the cause of the deviation and ensuring corrective actions are implemented.

4. Accountability

The

Production Manager is accountable for ensuring that deviations are promptly identified and reported. The QA Manager is responsible for overseeing the investigation, corrective actions, and ensuring that all deviations are properly documented and reviewed.

5. Procedure

5.1 Identification of Process Deviations

Follow these steps when a process deviation is identified:

  1. Monitor Production Activities

    1. Production personnel should continuously monitor manufacturing, filling, and packaging processes for any deviations from standard procedures or specifications.
    2. If any irregularities or non-conformances are observed, the production team must immediately identify the deviation and stop the process if necessary to prevent further impact on the batch.
  2. Report Deviation

    1. Immediately report the deviation to the QA team and document the incident in the Deviation Report Log (refer to Annexure 1).
    2. Ensure that the report includes the batch number, product name, the specific deviation observed, and the impact on production.
See also  Capsule: SOP for Disposal of Cleaning Residues from Capsule Machines - V 2.0

5.2 Investigation of Deviations

Once a deviation is reported, follow these steps for investigation:

  1. Root Cause Investigation

    1. The QA team will work with the production team to investigate the root cause of the deviation. This includes reviewing production records, equipment logs, and raw material information.
    2. Interview relevant personnel and observe the production process to gather additional information related to the deviation.
  2. Assess the Impact

    1. The QA team will evaluate the impact of the deviation on product quality and compliance. Determine whether the deviation affects the product’s safety, efficacy, or regulatory status.
    2. If necessary, determine whether the batch should be placed on hold, reworked, or rejected based on the severity of the deviation.

5.3 Corrective and Preventive Actions

After identifying the root cause, implement corrective and preventive actions:

  1. Corrective Actions

    1. Develop and implement corrective actions to address the root cause of the deviation and prevent recurrence. Corrective actions may include retraining personnel, adjusting equipment settings, or modifying procedures.
    2. Document corrective actions in the Deviation Report Log and assign responsibility for implementation.
  2. Preventive Actions

    1. Implement preventive actions to minimize the risk of similar deviations in the future. Preventive actions may involve revising standard operating procedures (SOPs) or introducing additional controls or checks.
    2. Monitor the effectiveness of preventive actions to ensure they prevent the recurrence of the deviation.
See also  Capsule: SOP for Screening Polymers for Capsule Coating - V 2.0

5.4 Documentation and Reporting

Document all process deviations thoroughly:

  1. Complete Deviation Report

    1. Ensure that the Deviation Report includes all relevant details, including the deviation description, root cause analysis, corrective and preventive actions, and impact on the batch.
    2. The Deviation Report should be signed off by the QA team and the responsible personnel.
  2. Submit to QA for Approval

    1. The completed Deviation Report is submitted to the QA Manager for review and approval. QA will ensure that the deviation is adequately addressed and that the corrective actions are implemented.
  3. Store Deviation Records

    1. Store all deviation records in a secure and organized location for future reference and audits.
    2. Ensure that deviation records are retained according to regulatory requirements (typically 5 years or as per local regulations).

5.5 Review and Monitoring

After the corrective actions have been implemented, follow these steps:

  1. Monitor Effectiveness

    1. Monitor the effectiveness of corrective actions to ensure that the deviation does not recur.
    2. Conduct periodic reviews of deviations to identify any recurring issues or patterns that may require further corrective actions.
  2. Periodic Audits

    1. Conduct regular audits of the deviation process to ensure compliance with this SOP and regulatory requirements.
    2. Ensure that all deviations are documented and reviewed in a timely manner.
See also  Capsule: SOP for Monitoring Capsule-Fill Density in Production - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • CoA: Certificate of Analysis

7. Documents

  1. Annexure 1: Deviation Report Template
  2. Annexure 2: Corrective Action Plan
  3. Annexure 3: Root Cause Analysis Template

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure 1: Deviation Report Template

Deviation ID Batch Number Deviation Date Deviation Description Root Cause Corrective Action Preventive Action Approval Status
DEV-001 Batch 001 01/03/2025 Temperature deviation during sealing Improper machine calibration Re-calibrate sealing machine Implement more frequent machine checks Approved

Annexure 2: Corrective Action Plan

Action ID Action Description Responsible Person Completion Date Status
CAP-001 Re-calibrate sealing machine John Doe 05/03/2025 Completed

Annexure 3: Root Cause Analysis Template

Root Cause Investigation Details Corrective Action Taken
Improper machine calibration Inspection of machine logs revealed irregular calibration data. Machine recalibrated and checked for consistency.

12. Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial version of SOP Creation of SOP for documenting deviations QA Head
01/02/2025 2.0 Updated deviation investigation process Added corrective and preventive action documentation QA Head
Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

Post navigation

Previous Post: BA-BE Studies: SOP for Review of Subject Recruitment Feasibility – V 2.0
Next Post: SOP for Risk Management Documentation in Medical Devices (ISO 14971)

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version